Epigenetic markers in circulating cell‐free DNA as prognostic markers for survival of castration‐resistant prostate cancer patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0045|78|5|336-342

ISSN： 0270-4137

Source： THE PROSTATE, Vol.78, Iss.5, 2018-04, pp. : 336-342

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

C-Reactive Protein is a Prognostic Marker for Patients with Castration-Resistant Prostate Cancer

By  

Oncology Research and Treatment, Vol. 39, Iss. 5, 2016-04 ,pp. : 266-271

Karger

Access to resources Recommend Favorite

Metastasis initiating cells in primary prostate cancer tissues from transurethral resection of the prostate (TURP) predicts castration‐resistant progression and survival of prostate cancer patients

By  

THE PROSTATE, Vol. 75, Iss. 12, 2015-07 ,pp. : 1312-1321

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical predictors of survival in men with castration‐resistant prostate cancer

By  

CANCER, Vol. 119, Iss. 16, 2013-08 ,pp. : 2990-2998

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical predictors of survival in men with castration‐resistant prostate cancer

By  

CANCER, Vol. 119, Iss. 22, 2013-11 ,pp. : 4052-4053

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reply to clinical predictors of survival in men with castration‐resistant prostate cancer

By  

CANCER, Vol. 119, Iss. 22, 2013-11 ,pp. : 4053-4054

John Wiley & Sons Inc

Access to resources Recommend Favorite